Register
Login:
Share:
Email Facebook Twitter




Add Immupharma to quick picks

Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 41.00Bid: 40.00Ask: 42.00Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 2.00Spread as %: 5.00%Open: 41.00High: 41.00Low: 41.00Yesterday’s Close: 41.00

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
41.00

Share Price SpacerBid
40.00

Share Price SpacerAsk
42.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
26,520

Share Price SpacerOpen
41.00

Share Price SpacerHigh
41.00

Share Price SpacerLow
41.00

Share Price SpacerClose
41.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 88.62m £36.34m 5,000

52 Week High 66.00 52 Week High Date 3-NOV-2014
52 Week Low 37.50 52 Week Low Date 21-JUL-2015

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 11,757 14,763 -11.953 -3.43 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

28-Aug-15
16:07:06
42.00
5,000
Buy* 
40.00
42.00
2,100
Trade Type:
Ordinary

28-Aug-15
15:58:14
41.9999
5,000
Buy* 
40.00
42.00
2,100
Trade Type:
Ordinary

28-Aug-15
08:59:18
40.80
8,757
Sell* 
40.00
42.00
3,573
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Today 21:35
boomorbust
L0ngterm
41.00
No Opinion

Yes, I assume we will be getting an RNS at some stage regarding the management structure. Not sure whether Dr Franco Di Muzio interim role as Chairman will become permanent. I had wondered whether our latest non-exec Dr Stéphane Méry may be involved in any new structure. I guess time will tell.
Today 14:41
L0ngterm
RE: Disappointed...
41.00
No Opinion

amendment to the start date mentioned, Clinical Trials states September (so can only assume Tuesday).
Today 14:33
L0ngterm
RE: Disappointed...
41.00
No Opinion

I was working on the basis that September would be the month for news. Hoping for: an update on phase III (RNS stated autumn for 1st dosing, hopefully early autumn) I noticed clinical trials processed the record on the 26th of August, Term sheet agreement details, Chairman update, possible an update on IPP-204106 Either way the official trial start date is Tuesday. So you never know Monday could be the start of the updates rolling out, and the end of the holidays season as well. All IMHO of course.
Today 09:28
cthed
Disappointed...
41.00
No Opinion

We've not heard anything this month...
Sun 19:35
boomorbust
RE: Imm
42.50
No Opinion

Yes could well do - will be very interesting to see the terms.
Sun 15:52
seagul
Imm
41.75
Strong Buy

Think we will see more info on the details of finance for stage 3 this week

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>
Please Login or Register to post messages






Sign up for Live Prices




Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.